- Research works
- 98 ▲ 66% vs 2013–17
- Citations
- 1.2k 12.1 per fractional work
- Top-10% rate
- 25.2% record average 16.5%
- Open access
- 63% world 28%
Not ranked overall: Ascendis Pharma (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 7.5×
- Immunology and Microbiology 5.0×
- Decision Sciences 3.3×
- Medicine 2.5×
- Nursing 1.8×
- Veterinary 1.3×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Business, Management and Accounting 1.1×
- Economics, Econometrics and Finance 1.0×
- Health Professions 0.7×
- Computer Science 0.6×
- Engineering 0.6×
- Materials Science 0.6×
- Chemistry 0.6×
- Energy 0.5×
- Social Sciences 0.4×
- Neuroscience 0.4×
- Arts and Humanities 0.3×
- Earth and Planetary Sciences 0.3×
- Mathematics 0.2×
- Psychology 0.2×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
Which keywords describe research at Ascendis Pharma (Denmark)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Cancer, Metabolism, Parathyroid Hormone, Growth Hormone, Inflammation, Postoperative Complications and Immunity.
- Insulin-like Growth Factors
- Hypoparathyroidism
- Neuroendocrine Control
- COVID-19
- Postoperative Complications
- Immunotherapy
- Quality of Life
- Deep Learning
- Growth Hormone
- Clinical Trials
- Cancer
- Epidemiology
- Inflammation
- Metabolism
- Parathyroid Hormone
- Pandemic
- Immunity
- Machine Learning
- Sustainability
- Healthcare
- Diagnosis
- IGF-1
- Thyroid Surgery
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Epidemiology2▲ 1.59×17 topics
- Cancer2▲ 4.5×8 topics
- Inflammation2▲ 2.8×11 topics
- Clinical Trials2▲ 7.8×9 topics
- Metabolism2▲ 8.6×2 topics
- Growth Hormone2▲ 85×2 topics
- Parathyroid Hormone2▲ 45×3 topics
- Deep Learning2▲ 1.17×8 topics
- Pandemic2▲ 3.6×5 topics
- Quality of Life1▲ 2.5×5 topics
- Immunity1▲ 8.0×4 topics
- Immunotherapy1▲ 4.8×7 topics
- Machine Learning1◆ 1.05×6 topics
- Postoperative Complications1▲ 25×3 topics
- Sustainability1▲ 1.28×3 topics
- COVID-191▲ 2.1×3 topics
- Healthcare1▲ 2.4×4 topics
- Neuroendocrine Control1▲ 106×2 topics
- Diagnosis1▲ 2.8×10 topics
- Hypoparathyroidism1▲ 117×1 topic
- IGF-11▲ 149×1 topic
- Insulin-like Growth Factors1▲ 149×1 topic
- Thyroid Surgery1▲ 117×1 topic
Which research topics does Ascendis Pharma (Denmark) publish most on?
By volume in 2022–2025: Thyroid and Parathyroid Surgery, Growth Hormone and Insulin-like Growth Factors, Complex Systems and Decision Making and Immune cells in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Thyroid and Parathyroid Surgery Surgery 1 works
- 2 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
- 3 Complex Systems and Decision Making Management Science and Operations Research 1 works
- 4 Immune cells in cancer Immunology 1 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 6 Parathyroid Disorders and Treatments Nephrology 1 works
- 7 Pituitary Gland Disorders and Treatments Endocrinology, Diabetes and Metabolism 1 works
- 8 Pharmaceutical industry and healthcare Pharmacology 0 works
- 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 10 Women's cancer prevention and management Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ascendis Pharma (Denmark)'s research output changed?
Output in 2018–2022 was 66% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Copenhagen
- University of Copenhagen
- Rigshospitalet
- Copenhagen Business School
- Copenhagen University Hospital
- Gentofte Hospital
- Bispebjerg Hospital
- Statens Serum Institut
- Novo Nordisk (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.